文献速递慢性静脉疾病静脉血栓栓塞

大隐静脉射频消融术后不延长血栓预防的疗效与安全性:TRAIN非劣效随机对照试验

Efficacy and Safety of No Thromboprophylaxis after Endovenous Radiofrequency Ablation for Incompetent Saphenous VeiNs: the TRAIN Non-inferiority Randomised Controlled Trial.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2026-10-15

结果显示不延长预防策略在30天内血栓相关事件上非劣效于利伐沙班,且未增加出血风险。

要点

  • 无既往下肢DVT患者RFA术后可考虑省略延长药物血栓预防。
  • 抗凝组出现1例临床相关非大出血,不抗凝组无出血事件。

核心结论

  • 预防性利伐沙班未与出血风险增加相关。

研究设计与样本

  • TRAIN为多中心、评估者盲法、非劣效随机对照试验。
  • 筛查406例,意向性治疗分析纳入354例,符合方案分析纳入304例。

主要发现

  • 抗凝组177例中1例(0.6%)在术后第10天发生临床相关非大出血;不抗凝组177例中0例出血(p=1.0)。

关键数值与推荐

  • 主要结局为30天内血栓相关事件。
  • 抗凝组临床相关非大出血1/177(0.6%),不抗凝组0/177,p=1.0。

临床怎么用

  • 对于无既往下肢DVT、接受RFA联合属支静脉切除术和/或泡沫硬化治疗的患者,术后可考虑不进行延长药物血栓预防。
  • 术中单次普通肝素后省略延长利伐沙班,未观察到血栓相关事件增加或出血风险升高。

局限性

  • 原文摘要未报告具体局限性描述。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The benefit of post-operative pharmacological thromboprophylaxis after endovenous radiofrequency ablation (RFA) for incompetent saphenous veins in patients without previous deep vein thrombosis (DVT) of the lower limbs is unclear. This trial compared no extended thromboprophylaxis with extended anticoagulation after RFA. METHODS: TRAIN (Thromboprophylaxis after endovenous Radiofrequency Ablation for Incompetent saphenous veiNs) was a multicentre, evaluator blinded, non-inferiority randomised controlled trial. Adults with primary great saphenous vein incompetence undergoing RFA, with concomitant tributary phlebectomy and or ultrasound guided foam sclerotherapy when clinically indicated, were enrolled. Patients with previous DVT of the lower limbs were excluded. All participants received a single intra-operative intravenous dose of unfractionated heparin and were randomised to either no extended pharmacological thromboprophylaxis or rivaroxaban 10 mg once daily for fourteen days post-operatively. The primary outcome was thrombosis related events within thirty days. RESULTS: Of 406 patients screened, 354 were included in the intention to treat analysis and 304 in the per protocol analysis. The no extended thromboprophylaxis strategy was non-inferior to fourteen days of rivaroxaban 10 mg once daily for thrombosis related events (risk difference -1.34%, 95% confidence interval -7.53 - 4.84%; p = .022 for non-inferiority). One participant in the anticoagulation group (one of 177; 0.6%) experienced clinically relevant non-major bleeding on post-operative day 10. No bleeding event occurred in the no anticoagulation group (0 of 177; p = 1.0). CONCLUSION: Omitting extended post-operative rivaroxaban thromboprophylaxis after RFA with concomitant phlebectomy and sclerotherapy in patients without previous DVT was non-inferior to fourteen days of rivaroxaban 10 mg once daily for thrombosis related events. Prophylactic rivaroxaban was not associated with an increased risk of bleeding.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Qi Y, Wang J, Weng C, et al. Efficacy and Safety of No Thromboprophylaxis after Endovenous Radiofrequency Ablation for Incompetent Saphenous VeiNs: the TRAIN Non-inferiority Randomised Controlled Trial. Eur J Vasc Endovasc Surg. 2026. PMID: 42880395. doi:10.1016/j.ejvs.2026.10.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。